Employers, lawmakers and more said regulators should hustle to get disclosure mandates for the controversial drug middlemen ...
If confirmed by the Senate, Schwartz could finally fill a void for an agency that’s cycled through multiple leaders over the last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results